Probiotic Allergy Prevention Study
The role of probiotics in the prevention of allergic disease in infancy
Prof Susan Prescott
180 participants
Jun 15, 2002
Interventional
Conditions
Summary
To aim of this study is to investigate the effects of probiotic supplementation for the first 6 months of life in infants at high risk of allergic disease. The study has been designed to determine if this intervention reduces the risk of developing allergic sensitisation (determined by allergy skin testing) and allergic disease (such as food allergy, atopic dermatitis and asthma) in early childhood. The participants and investigators remained blind to the intervention throughout the follow up period.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A randomised contriol trial: 3 billion Lactobacillus acidophilus LAVRI-A1 in maltodextrin (Probiomics, Australia) per day (or placebo) from birth to 6 months. This is given as a sachet of dried powder which is mixed with water and administered orally. The rate of development of allergic disease will be compared between these groups at 12 months, 2 years and 5 years - as indicated below.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12606000280505